
Oleptiss 180mg Tablet DT
Marketer
Novartis India Ltd
Salt Composition
Deferasirox (180mg)
Overview Oleptiss 180mg Tablet DT
Ferroxamine 180mg delayed-release tablets treat chronic iron excess from repeated blood transfusions. This medication facilitates iron excretion, mitigating potential organ damage. Administer Ferroxamine 180mg on an empty stomach, adhering strictly to the prescribed dosage and schedule for optimal efficacy. Commonly reported side effects include nausea, headache, constipation, and diarrhea. Should these effects intensify or linger, consult your physician. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, and provide a complete list of all concurrent medications to ensure treatment safety.
Uses of Oleptiss 180mg Tablet DT
Managing Excess Iron
Major Benefits of Oleptiss 180mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Oleptiss 180mg Tablet DT in water before consumption. Administer on an empty stomach.
Common Side effects of Oleptiss 180mg Tablet DT:
- Nausea
- Headache
- Vomiting
- Rash
- Abdominal pain
- Constipation
- Itching
- Abdominal distension
- Diarrhea
How to use Oleptiss 180mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Oleptiss 180mg Tablet DT in water before consumption. Administer on an empty stomach.
How Oleptiss 180mg Tablet DT works:
Oleptiss 180mg Delayed-Release Tablets bind and eliminate surplus iron, primarily through fecal excretion. This mitigates the potential for organ injury.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Oleptiss 180mg Tablet DT may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Oleptiss 180mg DT tablets during pregnancy poses a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in life-threatening cases where potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Oleptiss 180mg DT tablets safely. Available human data indicate minimal infant risk associated with the medication.
DrivingUNSAFE
Taking an Oleptiss 180mg extended-release tablet might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving is inadvisable if these effects are experienced.
KidneyUNSAFE
The use of Oleptiss 180mg DT tablets is likely inadvisable for individuals with impaired kidney function and should be avoided. Medical advice is recommended.
LiverCAUTION
Patients with liver impairment should use Oleptiss 180mg Tablet DT cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Oleptiss 180mg Tablet DT :
Should you forget to take your Oleptiss 180mg Tablet DT, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, forgo the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed dosage.
Facts to Know About Oleptiss 180mg Tablet DT
| Label | Value |
|---|---|
| Chemical Type | Benzoate-triazole hybrid |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
